Danaher to acquire Genetix for $82M
Danaher has offered to acquire all of Genetix shares for £50 million ($82 million U.S.), and the board and shareholders of Genetix, headquartered in New Milton, England, have accepted the offer amounting to more than 77 percent of the issued share capital in aggregate.

The offer will become unconditional upon acceptance by the holders of not less than 90 percent of the Genetix issued and to be issued shares and is subject to customary closing conditions, said Danaher.

Genetix provides scientists and clinicians with solutions for imaging and intelligent image analysis with fiscal 2008 revenues of approximately £26 million ($42 million U.S.).

Washington, D.C. based-Danaher anticipates completing the transaction during the first quarter of 2010.